Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-centre, Multi-national Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

NCT02385214 is registered in ClinicalTrials.gov with Melanoma and Skin Cancer Trials Limited as lead sponsor.

NCT NCT02385214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02385214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-centre, Multi-national Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Lead sponsor
Melanoma and Skin Cancer Trials Limited
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 3, 2015
Completion date
August 5, 2026
Enrollment
400 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma by ajcc v7 stage